CStone Pharmaceuticals (2616.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.57B |
| Enterprise Value | 6.17B |
| P/E Ratio | -19.71 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 27.02 |
| Price/Book Ratio | 9.81 |
| Enterprise/Revenue | 25.37 |
| Enterprise/EBITDA | -23.36 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1.23 |
| Operating Margin | -1.2 |
AD
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | -0.65 |
Income Statement
| Revenue | 269.58M |
| Revenue/Share | 0.17 |
| Gross Profit | 51.25M |
| EBITDA | -403.85M |
| Net Income | -437M |
| Diluted EPS | -0.31 |
Balance Sheet
| Total Cash | 919.09M |
| Total Cash/Share | 0.63 |
| Total Debt | 348.67M |
| Total Debt/Equity | 0.57 |
| Current Ratio | 2.18 |
| Book Value Per Share | 0.42 |
Price History
| 52-Week Change | 14.05 |
| 52-Week High | 13.15 |
| 52-Week Low | 4.01 |
| Moving Average 50 Days | 7.67 |
| Moving Average 200 Days | 6.91 |
Statistics
| Average Volume | 14.37M |
| Shares Outstanding | 1.6B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
